Immune-related gene risk model establishment and role of key gene FUCA1 in malignant pleural mesothelioma
The risk score model provides a new perspective for screening potential populations to benefit from immunotherapy and predicting their survival. FUCA1 may be a potential prognostic biomarker and promising therapeutic target for patients with MPM.
Authors
- Fuyi Zhu (ORCID: https://orcid.org/0000-0002-5581-0081)
- Yuchao He
- Ran Zuo (ORCID: https://orcid.org/0000-0003-4174-5861)
- Lin Shi (ORCID: https://orcid.org/0000-0002-4934-6649)
- Dongqi Yuan
- Dingzhi Huang
- Yu Wang (ORCID: https://orcid.org/0000-0002-7982-7179)
- Liwei Chen (ORCID: https://orcid.org/0000-0002-8458-5661)
- Hua Guo (ORCID: https://orcid.org/0000-0003-0346-6052)
- Yi Luo (ORCID: https://orcid.org/0000-0003-0087-5045)
- Peng Chen (ORCID: https://orcid.org/0000-0002-0635-9220)
Institutions
- Capital Medical University (CN)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Inner Mongolia People's Hospital (CN)
- Beijing Children’s Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-05-23
- DOI
- https://doi.org/10.3389/fphar.2025.1577232
- Primary Topic
- Occupational and environmental lung diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China